Published Date：Mar.2021
Industry：Chemical & Material
Pages：101 Table Number：123
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Valsartan (API) market in this environment. In terms of revenue, this research report indicated that the global Valsartan (API) market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Valsartan (API) industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Zhejiang Huahai Pharmaceutical aims at producing XX K Units Valsartan (API) in 2020, with XX % production to take place in global market, Hetero Labs accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Valsartan (API) Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Valsartan (API) Market? Zhejiang Huahai Pharmaceutical Hetero Labs Mylan Aurobindo Pharma ... Major Type of Valsartan (API) Covered in XYZResearch report: 40mg 80mg 160mg 320mg Application Segments Covered in XYZResearch Market High blood pressure Heart failure Diabetic kidney disease For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Valsartan (API) Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 40mg -Product Introduction and Major Manufacturers 1.1.2 80mg -Product Introduction and Major Manufacturers 1.1.3 160mg -Product Introduction and Major Manufacturers 1.1.4 320mg -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Valsartan (API) Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China Valsartan (API) Market 3.1.1 Top Companies leading Valsartan (API) Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China Valsartan (API) Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU Valsartan (API) Market 3.2.1 Top Companies leading Valsartan (API) Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU Valsartan (API) Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA Valsartan (API) Market 3.3.1 Top Companies leading Valsartan (API) Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA Valsartan (API) Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan Valsartan (API) Market 3.4.1 Top Companies leading Valsartan (API) Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan Valsartan (API) Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India Valsartan (API) Market 3.5.1 Top Companies leading Valsartan (API) Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India Valsartan (API) Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia Valsartan (API) Market 3.6.1 Top Companies leading Valsartan (API) Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia Valsartan (API) Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America Valsartan (API) Market 3.7.1 Top Companies leading Valsartan (API) Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America Valsartan (API) Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 Valsartan (API) Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Valsartan (API) Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global Valsartan (API) Sales and Growth Rate (2021-2027) 5.2 Global Valsartan (API) Sales Value and Growth Rate (2021-2027) 6 Valsartan (API) Competitive Analysis 6.1 Zhejiang Huahai Pharmaceutical 6.1.1 Zhejiang Huahai Pharmaceutical Company Profiles 6.1.2 Zhejiang Huahai Pharmaceutical Product Introduction 6.1.3 Zhejiang Huahai Pharmaceutical Valsartan (API) Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 Hetero Labs 6.2.1 Hetero Labs Company Profiles 6.2.2 Hetero Labs Product Introduction 6.2.3 Hetero Labs Valsartan (API) Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 Mylan 6.3.1 Mylan Company Profiles 6.3.2 Mylan Product Introduction 6.3.3 Mylan Valsartan (API) Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 Aurobindo Pharma 6.4.1 Aurobindo Pharma Company Profiles 6.4.2 Aurobindo Pharma Product Introduction 6.4.3 Aurobindo Pharma Valsartan (API) Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global Valsartan (API) Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global Valsartan (API) Sales (K Unit) by Type (2026-2027) Figure Global Valsartan (API) Sales (K Unit) and Growth Rate (2026-2027) Figure Global Valsartan (API) Sales Market Share (%) by Type (2019 -2020) Table Global Valsartan (API) Sales Value (Million USD) by Type (2026-2027) Figure Global Valsartan (API) Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global Valsartan (API) Sales Value Market Share (%) by Type (2019-2020) Table Global Valsartan (API) Sales (K Unit) by Application (2026-2027) Table China Valsartan (API) Sales (K Unit) of Major Company (2016-2021) Table China Valsartan (API) Sales Market Share of Major Company (2016-2021) Table China Valsartan (API) Sales Value (Million USD) of Major Company (2016-2021) Figure China Valsartan (API) Sales Value (Million USD) and Growth Rate (2016-2021) Table China Valsartan (API) Sales Value Share of Major Company (2016-2021) Table China Valsartan (API) Price (USD/Unit), by Type (2019-2020) Table China Valsartan (API) Sales (Unit) by Type (2026-2027) Figure China Valsartan (API) Sales (Unit) by Type (2026-2027) Table EU Valsartan (API) Sales (K Unit) of Major Company (2016-2021) Table EU Valsartan (API) Sales Market Share of Major Company (2016-2021) Table EU Valsartan (API) Sales Value (Million USD) of Major Company (2016-2021) Figure EU Valsartan (API) Sales Value (Million USD) and Growth Rate (2016-2021) Table EU Valsartan (API) Sales Value Share of Major Company (2016-2021) Table EU Valsartan (API) Price (USD/Unit), by Type (2019-2020) Table EU Valsartan (API) Sales (Unit) by Type (2026-2027) Figure EU Valsartan (API) Sales (Unit) by Type (2026-2027) Table USA Valsartan (API) Sales (K Unit) of Major Company (2016-2021) Table USA Valsartan (API) Sales Market Share of Major Company (2016-2021) Table USA Valsartan (API) Sales Value (Million USD) of Major Company (2016-2021) Figure USA Valsartan (API) Sales Value (Million USD) and Growth Rate (2016-2021) Table USA Valsartan (API) Sales Value Share of Major Company (2016-2021) Table USA Valsartan (API) Price (USD/Unit), by Type (2019-2020) Table USA Valsartan (API) Sales (Unit) by Type (2026-2027) Figure USA Valsartan (API) Sales (Unit) by Type (2026-2027) Table Japan Valsartan (API) Sales (K Unit) of Major Company (2016-2021) Table Japan Valsartan (API) Sales Market Share of Major Company (2016-2021) Table Japan Valsartan (API) Sales Value (Million USD) of Major Company (2016-2021) Figure Japan Valsartan (API) Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan Valsartan (API) Sales Value Share of Major Company (2016-2021) Table Japan Valsartan (API) Price (USD/Unit), by Type (2019-2020) Table Japan Valsartan (API) Sales (Unit) by Type (2026-2027) Figure Japan Valsartan (API) Sales (Unit) by Type (2026-2027) Table India Valsartan (API) Sales (K Unit) of Major Company (2016-2021) Table India Valsartan (API) Sales Market Share of Major Company (2016-2021) Table India Valsartan (API) Sales Value (Million USD) of Major Company (2016-2021) Figure India Valsartan (API) Sales Value (Million USD) and Growth Rate (2016-2021) Table India Valsartan (API) Sales Value Share of Major Company (2016-2021) Table India Valsartan (API) Price (USD/Unit), by Type (2019-2020) Table India Valsartan (API) Sales (Unit) by Type (2026-2027) Figure India Valsartan (API) Sales (Unit) by Type (2026-2027) Table Southeast Asia Valsartan (API) Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia Valsartan (API) Sales Market Share of Major Company (2016-2021) Table Southeast Asia Valsartan (API) Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia Valsartan (API) Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia Valsartan (API) Sales Value Share of Major Company (2016-2021) Table Southeast Asia Valsartan (API) Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Valsartan (API) Sales (Unit) by Type (2026-2027) Figure Southeast Asia Valsartan (API) Sales (Unit) by Type (2026-2027) Table South America Valsartan (API) Sales (K Unit) of Major Company (2016-2021) Table South America Valsartan (API) Sales Market Share of Major Company (2016-2021) Table South America Valsartan (API) Sales Value (Million USD) of Major Company (2016-2021) Figure South America Valsartan (API) Sales Value (Million USD) and Growth Rate (2016-2021) Table South America Valsartan (API) Sales Value Share of Major Company (2016-2021) Table South America Valsartan (API) Price (USD/Unit), by Type (2019-2020) Table South America Valsartan (API) Sales (Unit) by Type (2026-2027) Figure South America Valsartan (API) Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of Valsartan (API) Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Valsartan (API) Figure Cost Structure of Valsartan (API) in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global Valsartan (API) Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global Valsartan (API) Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table Zhejiang Huahai Pharmaceutical Profiles Table Zhejiang Huahai Pharmaceutical Valsartan (API) Product Introduction Table Zhejiang Huahai Pharmaceutical Valsartan (API) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Zhejiang Huahai Pharmaceutical SWOT Analysis Table Hetero Labs Profiles Table Hetero Labs Valsartan (API) Product Introduction Table Hetero Labs Valsartan (API) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Hetero Labs SWOT Analysis Table Mylan Profiles Table Mylan Valsartan (API) Product Introduction Table Mylan Valsartan (API) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Mylan SWOT Analysis Table Aurobindo Pharma Profiles Table Aurobindo Pharma Valsartan (API) Product Introduction Table Aurobindo Pharma Valsartan (API) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
